Monica Viziano

Monica is a Senior Director in Alliance Management, part of Corporate Development.  As Alliance Manager, Monica has successfully developed and maintained important Gilead alliances: Atripla (BMS), Tamiflu (Roche), Vitekta and Stribild (JT) and, TDF for China and Japan (GSK).  Additionally, Monica has supported business development in numerous in-licensing efforts and has played a key role in negotiations for significant contract amendments.  

Monica joined Gilead in 2002.  Initially she managed a variety of projects in the antiviral portfolio, both in R&D and in life cycle management (including Truvada and Atripla). Later she became the Therapeutic Area PPM lead for HIV antivirals.  She also took on a key role in the development and execution of Portfolio Review.

Prior to Gilead, Monica was with GSK for 6 years, initially as a Medicinal Chemist and later in the Project Management group.  Prior to that, she was a Medicinal Chemist at the Schering Plough Research Institute.